[Can lorazepam be distinguished from other short-acting benzodiazepines in regard to brain damage and withdrawal symptoms?].
D014151:Anti-Anxiety Agents / Q000009:adverse effects*; D006801:Humans; D008140:Lorazepam / Q000009:adverse effects*; D013375:Substance Withdrawal Syndrome; D019966:Substance-Related Disorders
D014151:Anti-Anxiety Agents; D008140:Lorazepam
Onderscheidt lorazepam zich van andere kortwerkende benzodiazepinen wat hersenbeschadiging en onttrekkingsverschijnselen betreft?